USANA Health Sciences Inc (NYSE: USNA) has reported earnings for its first fiscal quarter (ending March 31) of $0.86 versus $0.95 for the same period a year ago — a decline of -9%. Relative to the consensus estimate of $0.80, this was a premium of $0.06. For the latest four quarters through March 31, E.P.S. were $3.21 compared to $3.39 a year ago — a decline of -5%.
Recent Price Action
On 4/30/24, USANA Health Sciences Inc (NYSE: USNA) stock declined by -3.4%, closing at $41.52. NORMAL trading volume accompanied the decline. The stock has been extremely weak relative to the market over the last nine months and has declined -6.1% during the last week.
Current PriceTarget Research Rating
USNA is expected to continue to be a Value Builder reflecting capital returns that are forecasted to exceed the cost of capital.
USANA Health Sciences has a current Value Trend Rating of D (Negative). With this rating, PTR’s two proprietary measures of a stock’s current attractiveness are providing inconsistent signals. USANA Health Sciences has a neutral Appreciation Score of 52 but a very low Power Rating of 14, and the Negative Value Trend Rating results.
Rating Review
In light of this new information and negative market action we are reviewing our current Overall Rating of D. This review will be completed in the next several days.
Be the first to comment